340B Stakeholders Weigh in on HRSA’s Proposal to Replace 340B Dispute Resolution Process

ADR
340B contract pharmacy loomed large in stakeholders’ comments on HRSA's proposed revamp of the 340B program’s administrative dispute resolution system.

The fight over 340B contract pharmacy loomed large in stakeholders’ comments last week on a proposed federal regulation to revamp the 340B program’s administrative dispute resolution system.

Health care provider groups, citing manufacturers’ contract pharmacy policies, said they

Read More »

340B Hospital Physician Affiliated with Free-Market Think Tank Says Abolishing 340B Should be on the Table in Health Affairs Essay

DiGiorgio
“Consideration could be given to abolishing" the 340B program, Dr. Anthony DiGiorgio of Zuckerberg San Francisco General Hospital and Trauma Center writes in the policy journal Health Affairs. DiGiorgio says he receives funding from a free-market think tank "on Medicaid and access to care issues."

A neurosurgeon at a San Francisco 340B hospital who once was a health policy fellow for U.S. Sen. Bill Cassidy (R-La.) and who is doing research for a free-market oriented think tank has written a stinging reply to

Read More »

Bernie Sanders Officially Named Chair and Bill Cassidy Ranking Republican of Senate HELP Panel

Sanders Cassidy
Sen. Bernie Sanders (I-Vt.) (left), is the new chair of the Senate HELP Committee and Sen. Bill Cassidy (R-La.) is its new ranking Republican.

The U.S. Senate committee with jurisdiction over 340B is officially under new leadership, with Bernie Sanders (I-Vt.) being seated as Health, Education, Labor, and Pensions chair last week and Bill Cassidy (R-La.) as ranking Republican.

The formal announcements

Read More »

GSK Announces Refunds for 340B Overcharges on Respiratory Drugs

GSK
GlaxoSmithKline said last week it would pay refunds for 340B overcharges occurring in Q1 2021.

Pharmaceutical manufacturer GlaxoSmithKline said last week it would pay refunds for 340B overcharges occurring in the first quarter of 2021, including overcharges for blockbuster respiratory drugs Trelegy and Nucala.

The refund notice posted Feb. 2 on the

Read More »

Drugmakers Urge Appeals Courts to Follow Third Circuit Ruling and Uphold 340B Contract Pharmacy Restrictions

Courtroom
Lilly, Novartis, and United Therapeutics want the appeals courts hearing their 340B contract pharmacy cases to follow the lead of the appeals court in AstraZeneca, Sanofi, and Novo Nordisk’s cases and uphold their 340B policies.

Drugmakers Lilly, Novartis, and United Therapeutics this week urged federal appeals courts in Chicago and Washington, D.C., to follow the lead of the appeals court in Philadelphia and uphold their restrictions on 340B providers’ use of contract pharmacies.   

Read More »

Bayer: 340B “Is Enriching Middlemen Versus Benefitting Patients”

Bayer
The 340B program has “strayed far from its original purpose, creating a profit stream that is enriching middlemen versus benefiting patients,” Bayer says.

While the 340B program “has merit when used as intended,” it has “strayed far from its original purpose, creating a profit stream that is enriching middlemen versus benefitting patients,” drug manufacturer Bayer told 340B Report yesterday.

Bayer gave

Read More »

The Potential Domino Effect of Tennessee’s HIV Federal Funding Cuts

SPONSORED CONTENT

On January 17th 2023, a letter was sent from the Tennessee Department of Health (DOH) to Tennesseans serving “as notification of changes in the HIV Program.”  The letter informed federal grantees that they will no longer receive CDC funded HIV ‘in-kind support and services’ and will need to find their own

Read More »

Upcoming End of COVID-19 Emergency Could Prompt HRSA to End or Scale Back 340B Flexibilities

COVID-19 PHE
The Biden administration plans to end the nationwide COVID-19 public health emergency on May 11.

The Biden administration said on Monday that it plans to end the nationwide COVID-19 public health emergency on May 11. When the PHE ends, COVID-related 340B program flexibilities announced in March 2020 could end too.

The U.S. Health

Read More »

AHA Seeks Meeting with HHS About Repaying 340B Hospitals for Illegal Medicare Drug Reimbursement Cuts

AHA
The AHA wants to meet with HHS to hear how the government will repay 340B hospitals for five years’ worth of illegal Medicare Part B drug reimbursement cuts.

The American Hospital Association yesterday asked to meet with the team of federal officials that will decide how the government will repay 340B hospitals for five years’ worth of illegal Medicare Part B drug reimbursement cuts. The amount

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors